BHBP Current Tenants
Broad Hollow Bioscience Park (BHBP) is proud to host innovative biotech companies that are shaping the future of life sciences. Our tenants benefit from a collaborative ecosystem that offers access to state-of-the-art facilities, mentorship opportunities, and partnerships with Farmingdale State College faculty. From engaging in cutting-edge research projects to leveraging shared resources and equipment, BHBP provides the tools and support needed for early-stage companies to thrive. Together, we’re fostering growth and innovation.
Mispro Biotech Services, Inc.
Mispro advances human health by ensuring that drug discovery and development teams have the facilities and supporting laboratory animal services they need to successfully conduct effective animal research studies.
Estee Lauder Companies Inc.
The Estée Lauder Companies Inc. is one of the world's leading manufacturers and marketers of quality skin care, makeup, fragrance and hair care products
Codagenix Inc.
Codagenix is combining codon deoptimization with live-attenuated viruses for a vaccine and therapeutic platform poised to transform global health.
Kelm Academy, Inc.
Kelm Academy is a professional development school and career academy. We give individuals an education and experience that set them up for long-term success in their careers. As they discover the field they’re passionate about, they excel -- and dare to become leaders. Programs are offered online or onsite.
CMS BioTechnologies, Inc.
CMS BioTechnologies, Inc. provides chiral molecule separation to pharmaceutical companies and research facilities to greatly reduce the adverse side effects of prescription and over-the-counter drugs.
EpiBone
EpiBone is a revolutionary bone reconstruction company that allows patients to “grow their own bone”. EpiBone’s pioneering technology utilizes a scan of the patient’s bone defect and the patient’s own stem cells to construct and cultivate a defect-specific autologous-like bone graft.
DepYmed
DepYmed is developing potent inhibitors of the enzyme PTP1B which can be applied as potential therapeutic agents for multiple diseases including Rett Syndrome, Wilson Disease and cancer.
AccelBio
AccelBio provides Robotic Cell-based Assays and Diagnostic Services solutions for biotechnology and Pharma companies as well as academic labs and non-profit institutes. Our contract services enable the highest quality R&D focused on genetic models and disease pathways.
Calder Bioscience
Calder Biosciences is a nano-scale molecular engineering company developing next generation best-in-class conformationally-stabilized Universal Influenza and RSV recombinant subunit vaccines.
BHBP Former Tenants
BF Innovation
BF Innovation (BFI) designs prototype formulations for drug products. The objective of the company is to perform the R&D laboratory work on products using active pharmaceutical ingredients, performing the necessary lab work to arrive at a stable, safe and effective formulation. The R&D laboratory work will be submitted to regulatory agencies for new drug applications.
Certego Therapeutics Inc.
Certego Therapeutics Inc. is a biotechnology company that uses a proprietary Pharmacomap™ method of screening neural activation across the entire brain for drug discovery in neuroscience. Certego Therapeutics' goal is to radically improve predictability from preclinical studies to human outcomes in clinical trials. Our Pharmacomap™ method is applicable for screening of novel compounds being developed for a broad spectrum of brain disorders, including neurodevelopmental, psychiatric and neurodegenerative ones, as well as repurposing of existing drugs.
ProtiFi
ProtiFi makes sample prep solutions for proteomics, the study of all the proteins of a state of health or disease. Our sample processing system, called the S-Trap, provides a hitherto impossible solution of "one protocol for all samples." Because of its usefulness, speed and robustness, ProtiFi's sample preparation solutions have experienced rapid uptake in industrial biotech and academia.
OSI Pharmaceuticals
OSI Pharmaceuticals, LLC, acquired by Astellas Pharma on June 9, 2010 (www.astellas.us), is a member of the Astellas U.S. group of companies. OSI is an oncology drug discovery and translational research organization primarily focused on the discovery of molecular targeted therapies (MTTs). Following its 2010 acquisition by Astellas, OSI has become Astellas' center of excellence for oncology small molecule discovery research.
Helicon Therapeutics, Inc.
Helicon Therapeutics, Inc., founded in 1997, merged with Dart NeuroSciences, LLC on January 1, 2012 (www.dartneuroscience.com). Dart Neurosciences’ mission is to become the leading specialized pharmaceutical company for memory disorders by focusing on the discovery and development of innovative drugs with new mechanisms of action. These discoveries are firmly based in a careful examination of the genes involved in the reorganization of synaptic connections in the brain, a cellular/molecular process which underlies both implicit (motor skills) and explicit (facts and events) forms of memory.
IRX Therapeutics, Inc.
IRX Therapeutics, Inc. is focused on improving cancer treatments. IRX develops immune therapies designed to activate a patient’s immune system to defeat cancer and related diseases. The lead platform technology, IRX-2, is thought to broadly restore the immune system by overcoming cancer-induced immune suppression.
MitoGenetics
MitoGenetics is a limited liability company organized under Iowa law in December 2010, is the exclusive license holder of a biomedical technology (the "technology") designed by our licensor, The Research Foundation of State University of New York. The company's focus is mitochondria dysfunction which has been linked to certain disorders and diseases of the human body such as Autism, Parkinson's, Lou Gehrig's, muscular dystrophy, and chronic fatigue.